Active substances

Labetalol›

C07AG01 Cardiovascular system | Beta blocking agents | Beta blocking agents | Alpha and beta blocking agents

Indicated for: hypertension

Lacidipine›

C08CA09 Cardiovascular system | Selective calcium channel blockers with mainly vascular effects | Dihydropyridine derivatives

Indicated for: hypertension

Lacosamide›

N03AX18 Nervous system | Antiepileptics | Antiepileptics | Other antiepileptics

Indicated for: epilepsy

Lactic calcium›

A12AA05 Alimentary tract and metabolism | Calcium

Indicated for: calcium deficiency; osteoporosis

Lactobacillus›

G01AX14 Genito urinary system and sex hormones | Antiinfectives and antiseptics, excl. combinations with corticosteroids | Other antiinfectives and antiseptics

Indicated for: restoration of intestinal flora

Lactobacillus acidophilus + estriol›

G01AX14 Genito urinary system and sex hormones | Antiinfectives and antiseptics, excl. combinations with corticosteroids | Other antiinfectives and antiseptics

Indicated for: vaginal atrophy; restoration of vaginal flora

Lactulose›

A06AD11 Alimentary tract and metabolism | Drugs for constipation | Drugs for constipation | Osmotically acting laxatives

Indicated for: constipation; hepatic encephalopathy

Lamivudine›

J05AF05 Antiinfectives for systemic use | Direct acting antivirals | Nucleoside and nucleotide reverse transcriptase inhibitors

Indicated for: HIV-1 infection; chronic hepatitis B

Lamivudine + tenofovir disoproxil›

J05AR12 Antiinfectives for systemic use | Direct acting antivirals | Antivirals for treatment of HIV infections, combinations

Indicated for: HIV-1 infection

Lamivudine + zidovudine›

J05AR01 Antiinfectives for systemic use | Direct acting antivirals | Antivirals for treatment of HIV infections, combinations

Indicated for: HIV-1 infection

Lamotrigine›

N03AX09 Nervous system | Antiepileptics | Antiepileptics | Other antiepileptics

Indicated for: epilepsy; bipolar disorder

Lanadelumab›

B06AC05 Blood and blood forming organs | Other hematological agents | Other hematological agents | Drugs used in hereditary angioedema

Indicated for: hereditary angioedema

Landiolol›

C07AB14 Cardiovascular system | Beta blocking agents | Beta blocking agents | Beta blocking agents, selective

Indicated for: cardiac arrhythmias

Lanreotide›

H01CB03 Systemic hormonal preparations, excluding sex hormones and insulins | Hypothalamic hormones | Somatostatin and analogues

Indicated for: acromegaly; neuroendocrine tumors

Lansoprazole›

A02BC03 Alimentary tract and metabolism | Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) | Proton pump inhibitors

Indicated for: peptic ulcer; gastroesophageal reflux

Lanthanum›

V03AE03 Various | All other therapeutic products | All other therapeutic products | Drugs for treatment of hyperkalemia and hyperphosphatemia

Indicated for: hyperphosphatemia

Lapatinib›

L01EH01 Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors

Indicated for: cancer

Large bush velvet extract›

G02CX03 Genito urinary system and sex hormones | Other gynecologicals | Other gynecologicals

Indicated for: herbal symptomatic treatment

Laronidase›

A16AB05 Alimentary tract and metabolism | Other alimentary tract and metabolism products | Other alimentary tract and metabolism products | Enzymes

Indicated for: lysosomal enzyme deficiency

Larotrectinib›

L01EX12 Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Other protein kinase inhibitors

Indicated for: cancer

Latanoprost›

S01EE01 Sensory organs | Antiglaucoma preparations and miotics | Prostaglandin analogues

Indicated for: glaucoma; ocular hypertension

Latanoprost + netarsudil›

S01EE51 Sensory organs | Antiglaucoma preparations and miotics | Prostaglandin analogues

Indicated for: glaucoma; ocular hypertension

Latanoprost + timolol›

S01ED51 Sensory organs | Antiglaucoma preparations and miotics | Beta blocking agents

Indicated for: glaucoma; ocular hypertension

Lauromacrogol 400›

C05BB02 Cardiovascular system | Antivaricose therapy | Sclerosing agents for local injection

Indicated for: varicose veins; venous sclerotherapy

Lavender›

N05BX05 Nervous system | Anxiolytics | Other anxiolytics

Indicated for: mild restlessness; minor sleep disorders

Lazertinib›

L01EB09 Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors

Indicated for: non-small cell lung cancer

Ledipasvir + sofosbuvir›

J05AP51 Antiinfectives for systemic use | Direct acting antivirals | Antivirals for treatment of HIV infections

Indicated for: chronic hepatitis C

Leflunomide›

L04AA13 Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Selective immunosuppressants

Indicated for: rheumatoid arthritis

Lenacapavir›

J05AX31 Antiinfectives for systemic use | Direct acting antivirals | Other antivirals

Indicated for: HIV-1 infection

Lenalidomide›

L04AX04 Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Other immunosuppressants

Indicated for: multiple myeloma